Genesis Growth Tech Acquisition Inks $21M Deal with MindMaze
Genesis Growth Tech Acquisition in an 8-K said it entered into a business combination agreement with digital therapeutics firm Mind Maze for $21 million. Founded in 2012, MindMaze is engaged in brain technology with a mission to accelerate humanity’s ability... Read More →
Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
CAMBRDIGE, Mass. and SECAUCUS, N.J., Nov. 20, 2023 /PRNewswire/ — Universal DX (“UDX”), a biotech company on a mission to transform cancer into a curable disease, today announced a strategic collaboration with Quest Diagnostics (“Quest”) (NYSE: DGX), the nation’s leading... Read More →
Innovative Research, Inclusive Trials, and New Funding Drives Hope for People with Parkinson’s Disease featuring PhotoPharmics
PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization This investment is a pivotal moment in our journey to transform the treatment landscape for Parkinson’s disease.”— Kent Savage, CEO AMERICAN FORK, UT,... Read More →
Koya Medical Raises New Capital with OrbiMed to Support Growth
OAKLAND, Calif. and NEW YORK, Nov. 15, 2023 /PRNewswire/ — OrbiMed, a leading healthcare investment firm and Koya Medical, a healthcare company with a mission to transform venous and lymphatic treatments through novel, people-centric solutions, today announced the closing of... Read More →
Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics
OXFORD, England and BOSTON, Nov. 14, 2023 /PRNewswire/ — Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, and Day Zero Diagnostics (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI... Read More →
Neurent Medical Announces New CPT Code® for Chronic Rhinitis Treatment Offering Significant Symptom Improvements
GALWAY, Ireland, Nov. 13, 2023 /PRNewswire/ — Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced a significant milestone for the chronic rhinitis market. The Centers for Medicare and Medicaid Services (CMS) has... Read More →
Houston Innovation Awards winners revealed at 2023 event
The winner of the Life Science Business category, honoring an innovative company within the health and medical industries designing a treatment or technology, is CellChorus, using AI to evaluate immune cell function and performance to improve the development and delivery... Read More →
Remote Medication Monitor Receives Funding from Rady Venture Fund featuring Cari Health
CARI Health enables clinicians to view medication levels in real-time and customize dosages for every patient he Rady Venture Fund, a student-assisted venture capital investment fund, established at the Rady School of Management in 2009 to support the school’s educational... Read More →
Avenda Health’s Revolutionary AI Mapping Tool for Prostate Cancer Achieves Landmark Category III CPT Code Designation
Reimbursement code improves access to personalized prostate cancer care with Avenda Health’s AI cancer mapping platform, Unfold AI™ CULVER CITY, Calif., Nov. 1, 2023 /PRNewswire/ — The American Medical Association (AMA) has announced its 2024 Current Procedural Terminology (CPT) code... Read More →